The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Sections

Evaluating Antidepressant Studies | Outcome Assessments | Safety and Tolerability | Selective Serotonin Reuptake Inhibitors | Atypical Antidepressants | Tricyclic Antidepressants | Monoamine Oxidase Inhibitors | Alternative Antidepressant Treatments | References

Excerpt

Antidepressants are widely used in children and adolescents for a variety of disorders, with significant increases over the past 20 years. Primarily, antidepressants have been used for the same disorders as in adults (depression, anxiety), with additional potential use for ADHD, repetitive behaviors (e.g., autism spectrum disorders), and reactive aggression. Newer antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), have shown efficacy and safety in children and adolescents, with the greatest effect seen in obsessive-compulsive disorder (OCD) and anxiety disorders, followed by major depressive disorder (MDD). Limited data are available on pharmacokinetics and dosing in this age group, but medication dose and frequency may require adjustment (see also Chapter 33, “Principles of Psychopharmacology”).

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Institutional Login
  • Sign in via OpenAthens
  • Register for access
  • Please login/register if you wish to pair your device and check access availability.

    Not a subscriber?

    Subscribe Now / Learn More

    PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).